Beyond its role in the initiation of digestion, the oral microbiome appears to be key to maintaining both oral and systemic ...

BenQ is stepping into new territory with the launch of its first 4K 144Hz professional monitor, the PD3226G, designed for ...

Scientists have attempted to map the human cell since the first microscope was invented more than 400 years ago. But many ...

The FDA has approved Bristol Myers Squibb's Opdivo and Yervoy as first-line therapy for patients with a particular form of ...

The US Department of Commerce is reportedly investigating TSMC for letting chips enter Huawei's AI products, potentially ...

US President Donald Trump has announced a sweeping new tariff regime. Among the hardest hit are Cambodia and Vietnam, with ...

Patients who take foslevodopa/foscarbidopa who wake in the "ON" state show improved motor function, daily activities, and ...

Blarcamesine is a sigma 1 receptor agonist which targets Alzheimer's pathology upstream of amyloid and tau pathology.

While conventional treatments for PD focus on dopamine replacement, growing research highlights the potential of ...

At NAB 2025 in Las Vegas, we caught up with MID49 to check out their new Power Distribution for the Canon C70/80, C400, Sony FX6/FX9, BURANO, and ...

Exercise is the most promising disease-modifying therapy for Parkinson's Disease. And doctors need to prescribe it.

Roche Holdings AG (OTC:RHHBY) on Thursday presented new data at the AD/PD 2025 International Conference on Alzheimer’s and ...